5-(benzylthio)-2-methylpyridine | 907202-06-6

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: 5-(benzylthio)-2-methylpyridine
• 英文别名: 2-methyl-5-benzylthiopyridine；5-benzylsulfanyl-2-methylpyridine
• CAS: 907202-06-6
• 化学式: C₁₃H₁₃NS
• 分子量: 215.319
• InChiKey: YKUSSSJWTQRYGR-UHFFFAOYSA-N

物化性质

• 沸点：
  338.3±30.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.15
• 拓扑面积：
  38.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  5-(benzylthio)-2-methylpyridine 在 N-氯代丁二酰亚胺 作用下， 以 水 、 溶剂黄146 为溶剂， 反应 2.0h， 以45%的产率得到6 -甲基吡啶- 3 -磺酰氯
  参考文献：
  名称：

  [EN] HEPATITIS B VIRAL ASSEMBLY EFFECTORS
  [FR] EFFECTEURS D'ASSEMBLAGE DE VIRUS DE L'HÉPATITE B

  摘要：

  揭示了一种对乙型肝炎病毒（HBV）感染具有治疗效果的新型组装效应子化合物。本文描述的组装效应子分子可以导致病毒组装缺陷，也可能影响与慢性HBV感染相关的其他病毒活动。还公开了一种合成所述化合物的方法，通过给予所述化合物治疗HBV的方法，以及利用这些化合物制造针对HBV的药物的用途。

  公开号：

  WO2016168619A1
• 作为产物：
  描述：

  5-溴-2-甲基吡啶 、 苄硫醇 在 tris-(dibenzylideneacetone)dipalladium(0) 、 三乙胺 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 作用下， 以 甲苯 为溶剂， 反应 16.0h， 以95%的产率得到5-(benzylthio)-2-methylpyridine
  参考文献：
  名称：

  [EN] HEPATITIS B VIRAL ASSEMBLY EFFECTORS
  [FR] EFFECTEURS D'ASSEMBLAGE DE VIRUS DE L'HÉPATITE B

  摘要：

  揭示了一种对乙型肝炎病毒（HBV）感染具有治疗效果的新型组装效应子化合物。本文描述的组装效应子分子可以导致病毒组装缺陷，也可能影响与慢性HBV感染相关的其他病毒活动。还公开了一种合成所述化合物的方法，通过给予所述化合物治疗HBV的方法，以及利用这些化合物制造针对HBV的药物的用途。

  公开号：

  WO2016168619A1

文献信息

• 5-Membered heterocyclic compound
  申请人：Nishida Haruyuki

  公开号：US20090156642A1

  公开（公告）日：2009-06-18

  The present invention provides 5-membered heterocycle compounds represented by the following general formula (I): The present compounds have a superior acid secretion inhibitory effect, and shows an antiulcer activity and the like.

  本发明提供了以下通式(I)表示的5元杂环化合物： 本化合物具有优异的抑制胃酸分泌效果，并显示出抗溃疡活性等。
• [EN] METHOD FOR PRODUCING THIOETHER COMPOUND<br/>[FR] MÉTHODE DE SYNTHÈSE D'UN COMPOSÉ DE TYPE THIOÉTHER
  申请人：BANYU PHARMA CO LTD

  公开号：WO2006038741A1

  公开（公告）日：2006-04-13

  Disclosed is an efficient and widely-applicable method for commercially producing a thioether compound or a thiol compound which is useful as a pharmaceutical product or a production intermediate of a pharmaceutical product. Specifically disclosed is a method for producing a thioether compound represented by the general formula [I] below or a salt thereof. This method is characterized in that a compound represented by the following general formula [III]: [III] (wherein X represents a bromine atom, a chlorine atom or a trifluoromethylsulfonyloxy group, and ring A represents an aryl group or a heteroaryl ring group) or a salt thereof is reacted with a thiol compound represented by the following general formula [II]: [II] or a salt thereof in the presence of a palladium compound such as Pd2(dba)3, a base such as i-Pr2NEt and a phosphorus compound represented by the following formula [AA].

  公开了一种高效且广泛适用的方法，用于商业生产一种硫醚化合物或巯基化合物，该化合物可用作药物产品或药物产品的生产中间体。具体公开了一种生产下述通用式[I]所代表的硫醚化合物或其盐的方法。该方法的特征在于，在钯化合物（例如Pd2(dba)3）、碱（例如i-Pr2NEt）和下述式[AA]所代表的磷化合物存在下，通过将下述通用式[III]所代表的化合物（其中X代表溴原子、氯原子或三氟甲磺酰氧基团，环A代表芳基或杂环芳基团）或其盐与下述通用式[II]所代表的巯基化合物或其盐反应来实现。
• Method For Producing Thioether Compound
  申请人：Itoh Takahiro

  公开号：US20080108823A1

  公开（公告）日：2008-05-08

  Disclosed is an efficient and widely-applicable method for commercially producing a thioether compound or a thiol compound which is useful as a pharmaceutical compound or a production intermediate of it. Specifically disclosed is a method for producing a thioether compound represented by the general formula [I] below or a salt thereof. This method is characterized in that a compound represented by the following general formula [III]:[III] (wherein X represents a bromine atom, a chlorine atom or a trifluoromethylsulfonyloxy group, and ring A represents an aryl group or a heteroaryl ring group) or a salt thereof is reacted with a thiol compound represented by the following general formula [II]:[II] or a salt thereof in the presence of a palladium compound such as Pd 2 (dba) 3 , a base such as i-Pr 2 NEt and a phosphorus compound represented by the following formula [AA].

  公开了一种高效且广泛适用的方法，用于商业生产一种硫醚化合物或硫醇化合物，该化合物可用作药物化合物或其生产中间体。具体公开了一种制备下述一般式[I]所代表的硫醚化合物或其盐的方法。该方法的特点在于，在钯化合物（如Pd2（dba）3）、碱（如i-Pr2NEt）和下述式[AA]所代表的磷化合物的存在下，将下述一般式[III]所代表的化合物（其中X代表溴原子、氯原子或三氟甲基磺酰氧基团，环A代表芳基或杂环环基）或其盐与下述一般式[II]所代表的硫醇化合物或其盐反应。
• METHOD FOR PRODUCING THIOETHER COMPOUND
  申请人：BANYU PHARMACEUTICAL CO., LTD.

  公开号：EP1806337A1

  公开（公告）日：2007-07-11

  Disclosed is an efficient and widely-applicable method for commercially producing a thioether compound or a thiol compound which is useful as a pharmaceutical compound or a production intermediate of it. Specifically disclosed is a method for producing a thioether compound represented by the general formula [I] below or a salt thereof. This method is characterized in that a compound represented by the following general formula [III]: [III] (wherein X represents a bromine atom, a chlorine atom or a trifluoromethylsulfonyloxy group, and ring A represents an aryl group or a heteroaryl ring group) or a salt thereof is reacted with a thiol compound represented by the following general formula [II]: [II] or a salt thereof in the presence of a palladium compound such as Pd2(dba)3, a base such as i-Pr2NEt and a phosphorus compound represented by the following formula [AA].

  本发明公开了一种用于商业化生产硫醚化合物或硫醇化合物的高效且广泛适用的方法，硫醚化合物或硫醇化合物可用作药物化合物或其生产中间体。具体地说，本发明公开了一种生产以下通式[I]代表的硫醚化合物或其盐的方法。该方法的特征在于由以下通式[III]代表的化合物：[III]（其中 X 代表溴原子、氯原子或三氟甲基磺酰氧基，环 A 代表芳基或杂芳基环基）或其盐与下 列通式[II]代表的硫醇化合物反应：[II]或其盐在钯化合物如 Pd2(dba)3、碱如 i-Pr2NEt 和下式[AA]代表的磷化合物存在下反应。
• Hepatitis B viral assembly effectors
  申请人：Indiana University Research and Technology Corporation

  公开号：US10273228B2

  公开（公告）日：2019-04-30

  Novel assembly effector compounds having a therapeutic effect against hepatitis B viral (HBV) infection are disclosed. Assembly effector molecules described herein can lead to defective viral assembly and also may affect other viral activities associated with chronic HBV infection. Also disclosed is a process to synthesize disclosed compounds, method of treatment of HBV by administration of disclosed compounds, and use of these compounds in the manufacture of medicaments against HBV.

  本研究公开了对乙型肝炎病毒（HBV）感染有治疗作用的新型组装效应化合物。本文所述的组装效应分子可导致病毒组装缺陷，还可影响与慢性 HBV 感染相关的其他病毒活动。还公开了合成所公开化合物的工艺、通过服用所公开化合物治疗 HBV 的方法，以及这些化合物在制造抗 HBV 药物中的用途。